Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Christoph Vilanek, CEO of Freenet, discusses corporate culture and leadership in a video with viewer comments.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Christoph Vilanek, CEO of Freenet
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Elevating Investing for a Transformative Era |Joseph Sullivan, CEO , Allspring Global Investments.
00:10:00
Ultra Clean Holdings, Inc. reported a 30% increase in Q1 revenue despite a small miss, with its stock considered undervalued after the tech pullback.
00:10:00
Top 10 Considerations for Planning the Perfect Summer Getaway by Raquel Hinman | Raquel Hinman - Founder & Principal of Hinman Financial Planning, Inc.
00:10:00
Navigating IRA Contributions: A Tech Employee's Guide with Rebecca Conner | Rebecca Conner, Founder, SeedSafe Financial LLC.
00:10:00
Creactives Group Explores AI Challenges in the Supply Chain | Paolo Gamberoni, CEO , Creactives Group S P A.
00:10:00
Chris Cairns Highlights Stavely Minerals’ Cayley Lode Progress and Resource Estimate | Chris Cairns , Managing Director, Stavely Minerals Ltd.
00:10:00
Meeting Founders Before Theyre Founders|Alana Goyal,Founder and Managing Partner,base case capital
00:10:00
Commercial real estate prices are declining, suggesting a potential rebound in listed REITs, while the commercial real estate debt market appears healthier than commonly perceived.|Martin Cohen is Chairman of Cohen & Steers
00:10:00
3tentos CEO Luiz Osório Dumoncel on R$2 Billion Investment in Agribusiness and 2024 Growth | Luiz Osório Dumoncel, CEO, Três Tentos Agroindustrial SA.
00:10:00
Williams Financial, LLC discusses maintaining focus for the new year ahead.
00:00:00
Ulrich von Andrian Mallinckrodt Professor of Immunopathology at Harvard Medical School| Understanding Immune Cell Migration
00:10:00
Exploring Innovation and Sustainability in Real Estate with FCR Immobilien AG | Falk Raudies , CEO, FCR Immobilien AG.